Technology
Analysts Recommend Buying SharkNinja, Inc. (SN): Is It Time to Invest?
**SharkNinja, Inc. (SN) Receives Strong Analyst Recommendations** SharkNinja, Inc. (SN) has an Average Brokerage Recommendation (ABR) of 1.20, indicating a consensus between “Strong Buy” ...
United Homes Shares Drop Following Q4 Earnings Report as Revenue and Orders Decrease
United Homes Group, Inc. (UHG) reported a 12.3% revenue decline for 2025, totaling $406.7 million, down from $463.7 million in 2024. For the fourth ...
Willis Lease Finance Sees Yearly Drop in Q4 Earnings Amid Rising Expenses
Willis Lease Finance Corporation (WLFC) reported a 45.2% decline in net income, totaling $10.8 million for Q4 2025, down from $19.6 million in Q4 ...
Investors Eye Positive Outlook for Star Bulk Carriers (SBLK): Is It Time to Invest?
Star Bulk Carriers (SBLK) has an average brokerage recommendation (ABR) of 1.80, indicating a consensus between Strong Buy and Buy based on ratings from ...
Cava’s Growth Potential: Is Now the Time to Invest?
Cava Group (CAVA) currently holds an average brokerage recommendation (ABR) of 1.85, indicating a strong buy, based on assessments from 27 brokerage firms. Specifically, ...
Lockheed Martin and RTX: Key Players in Today’s Defense Industry
Lockheed Martin (LMT) and RTX Corporation (RTX) are increasing production of missiles and defense systems in response to heightened munitions usage during ongoing conflicts, ...
Hurco Shares Drop After Q1 Earnings Despite Increased Orders
Hurco Companies, Inc. (HURC) reported a net loss of $3.5 million, or $0.54 per diluted share, for the first quarter of fiscal 2026, a ...
Palladyne AI Reports Year-Over-Year Reduction in Q4 Loss Driven by Acquisition Growth
Palladyne AI Corp. (PDYN) reported a fourth-quarter adjusted net loss of 16 cents per share for the quarter ending December 31, 2025, an improvement ...
NRP Reports Yearly Decline in Q4 Earnings Due to Low Coal and Soda Ash Prices
Natural Resource Partners L.P. (NRP) reported a 27.5% decline in net income for Q4 2025, totaling $31 million, down from $42.8 million a year ...
Cumberland Experiences Year-over-Year Loss Reduction in Q4 Driven by Talicia Sales Surge
Cumberland Pharmaceuticals Inc. (CPIX) reported a 31% increase in net revenues for Q4 2025, totaling $13.7 million, despite a significant 29.5% decline in its ...
